全球生物净化市场规模、份额、趋势和成长分析报告（2026-2034）

预计生物净化市场将从 2025 年的 2.7861 亿美元成长到 2034 年的 6.1164 亿美元，2026 年至 2034 年的复合年增长率为 9.13%。

由于医疗保健、製药生产和实验室领域对感染控制的意识不断提高，全球生物净化市场正在成长。生物净化系统利用气化过氧化氢、紫外线照射和其他技术，在受控环境中去除病原体。新冠肺炎疫情显着加速了市场需求。

关键驱动因素包括更严格的监管要求、医院加强的感染控制措施以及生物製药生产中无尘室设施的扩建。技术创新提高了消毒系统的自动化程度、安全性和有效性。研究机构和高等级生物安全防护设施的增加也促进了市场成长。

随着感染预防成为医疗领域的长期优先事项，未来前景依然强劲。预计该技术的应用范围将从医院扩展到交通运输、公共基础设施和食品加工行业。永续性考量和成本效益高的系统设计将影响未来的产品开发，从而确保持续创新和稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球生物净化市场：依成分划分

• 市场分析、洞察与预测
• 装置
• 服务
• 消耗品

第五章：全球生物净化市场：依化学物质划分

• 市场分析、洞察与预测
• 过氧化氢
• 二氧化氯
• 过氧乙酸
• 二氧化氮

第六章：全球生物净化市场：依类型划分

• 市场分析、洞察与预测
• 舱室消毒
• 室内消毒

第七章：全球生物净化市场：依最终用途划分

• 市场分析、洞察与预测
• 生技公司和研究机构
• 製药和医疗设备製造商
• 生命科学研究机构和研究组织
• 医院和其他医疗机构
• 食品和饮料公司
• 其他的

第八章 全球生物净化市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Amira Srl
  • Clordisys Solutions Inc
  • Ecolab
  • Fedegari Autoclavi SPA
  • Howorth Air Technology Limited
  • Jce Biotechnology
  • Noxilizer Inc
  • Steris
  • Tomi Environmental Solutions Inc
  • Zhejiang Tailin Bioengineering Co. Ltd

The Bio Decontamination Market size is expected to reach USD 611.64 Million in 2034 from USD 278.61 Million (2025) growing at a CAGR of 9.13% during 2026-2034.

The global bio decontamination market has grown due to heightened awareness of infection control in healthcare, pharmaceutical manufacturing, and research laboratories. Bio decontamination systems use vaporized hydrogen peroxide, UV radiation, and other technologies to eliminate pathogens in controlled environments. The COVID-19 pandemic significantly accelerated market demand.

Drivers include stricter regulatory requirements, increased hospital-acquired infection prevention efforts, and expansion of cleanroom facilities in biopharma manufacturing. Technological innovations have improved automation, safety, and efficacy of decontamination systems. Growth in laboratory research and high-containment facilities further supports market expansion.

Future prospects remain strong as infection prevention becomes a permanent healthcare priority. Adoption will expand beyond hospitals to transportation, public infrastructure, and food processing industries. Sustainability considerations and cost-effective system designs will influence future product development, ensuring continued innovation and steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Equipment
• Services
• Consumables

By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

By Type

• Chamber Decontamination
• Room Decontamination

By End-use

• Biotech Companies & Research Organizations
• Pharmaceutical & Medical Device Manufacturers
• Life Science Laboratories & Research Organizations
• Hospital & Other Healthcare Facilities
• Food & Beverage Companies
• Others

COMPANIES PROFILED

• Amira Srl, Clordisys Solutions Inc, Ecolab, Fedegari Autoclavi SPA, Howorth Air Technology Limited, Jce Biotechnology, Noxilizer Inc, Steris, Tomi Environmental Solutions Inc, Zhejiang Tailin Bioengineering Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIO DECONTAMINATION MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIO DECONTAMINATION MARKET: BY AGENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Agent
• 5.2. Hydrogen Peroxide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chlorine Dioxide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Peracetic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nitrogen Dioxide Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIO DECONTAMINATION MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Chamber Decontamination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Room Decontamination Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIO DECONTAMINATION MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biotech Companies & Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical & Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Life Science Laboratories & Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospital & Other Healthcare Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Food & Beverage Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIO DECONTAMINATION MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Component
  • 8.2.2 By Agent
  • 8.2.3 By Type
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Component
  • 8.3.2 By Agent
  • 8.3.3 By Type
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Component
  • 8.4.2 By Agent
  • 8.4.3 By Type
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Component
  • 8.5.2 By Agent
  • 8.5.3 By Type
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Component
  • 8.6.2 By Agent
  • 8.6.3 By Type
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIO DECONTAMINATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Amira Srl
  • 10.2.2 Clordisys Solutions Inc
  • 10.2.3 Ecolab
  • 10.2.4 Fedegari Autoclavi S.P.A
  • 10.2.5 Howorth Air Technology Limited
  • 10.2.6 Jce Biotechnology
  • 10.2.7 Noxilizer Inc
  • 10.2.8 Steris
  • 10.2.9 Tomi Environmental Solutions Inc
  • 10.2.10 Zhejiang Tailin Bioengineering Co. Ltd